Cargando…
Identification of DRG-1 As a Melanoma-Associated Antigen Recognized by CD4(+) Th1 Cells
Immunotherapy has emerged as a promising strategy for the treatment of metastatic melanoma. Clinical studies have demonstrated the feasibility of cancer immunotherapy using tumor antigens recognized by CD8(+) T cells. However, the overall immune responses induced by these antigens are too weak and t...
Autores principales: | Kiniwa, Yukiko, Li, Jiang, Wang, Mingjun, Sun, Chuang, Lee, Jeffrey E., Wang, Rong-Fu, Wang, Helen Y. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4439028/ https://www.ncbi.nlm.nih.gov/pubmed/25993655 http://dx.doi.org/10.1371/journal.pone.0124094 |
Ejemplares similares
-
Identification of Special AT-Rich Sequence Binding Protein 1 as a Novel Tumor Antigen Recognized by CD8(+) T Cells: Implication for Cancer Immunotherapy
por: Wang, Mingjun, et al.
Publicado: (2013) -
Biochemical Identification of a Mutated Human Melanoma Antigen Recognized by CD4(+) T Cells
por: Pieper, Rembert, et al.
Publicado: (1999) -
Identification of Prostate-Specific G-Protein Coupled Receptor as a Tumor Antigen Recognized by CD8(+) T Cells for Cancer Immunotherapy
por: Matsueda, Satoko, et al.
Publicado: (2012) -
MELOE-1 Antigen Contains Multiple HLA Class II T Cell Epitopes Recognized by Th1 CD4+ T Cells from Melanoma Patients
por: Bobinet, Mathilde, et al.
Publicado: (2012) -
Identification of a Mutated Fibronectin As a Tumor Antigen Recognized by CD4(+)T Cells: Its Role in Extracellular Matrix Formation and Tumor Metastasis
por: Wang, Helen Y., et al.
Publicado: (2002)